| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |